Abstract
The efficacy of intraperitoneal chemotherapy (IPC) can be significantly enhanced by a temperature-sensitive liposomes (TSLs) administration. Magnetic hyperthermia (MHT) has the potential to provide sufficient heat for TSLs to release their contents. For the first time, we used computational modeling to simulate MHT combined with intraperitoneal (IP) delivery of doxorubicin-loaded temperature-sensitive liposomes (TSL-Dox). Results indicate that this combination therapy can improve treatment efficacy. The results also indicate that using large and octahedral MNPs can increase drug penetration by ten folds against normal IPC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
